Personal tools

MCL coexpression mm9:1223: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004119!2.95e-22!118;UBERON:0000925!2.95e-22!118;UBERON:0006595!2.95e-22!118;UBERON:0001007!9.65e-22!116;UBERON:0001555!9.65e-22!116;UBERON:0007026!9.65e-22!116;UBERON:0004921!1.76e-20!114;UBERON:0002193!1.19e-13!48;UBERON:0002405!1.19e-13!48;UBERON:0005409!2.16e-13!47;UBERON:0003929!5.03e-13!55;UBERON:0002390!5.67e-12!45;UBERON:0003061!5.67e-12!45;UBERON:0000160!1.06e-11!31;UBERON:0004923!7.81e-11!24;UBERON:0005911!2.90e-10!69;UBERON:0000344!4.39e-10!15;UBERON:0000490!1.31e-09!66;UBERON:0001041!5.38e-09!80;UBERON:0001242!7.22e-09!13;UBERON:0000060!7.22e-09!13;UBERON:0001262!7.22e-09!13;UBERON:0004786!7.22e-09!13;UBERON:0002384!2.23e-08!46;UBERON:0000077!6.81e-08!35;UBERON:0004177!1.18e-07!29;UBERON:0005057!1.18e-07!29;UBERON:0003408!4.93e-07!24;UBERON:0000072!5.06e-07!27;UBERON:0007023!5.60e-07!51;UBERON:0002370!7.02e-07!23;UBERON:0000974!7.02e-07!23;UBERON:0004807!7.02e-07!23;UBERON:0005058!7.02e-07!23;UBERON:0003351!7.02e-07!23;UBERON:0009113!7.02e-07!23;UBERON:0003295!7.02e-07!23;UBERON:0009722!7.02e-07!23;UBERON:0005562!7.02e-07!23;UBERON:0007690!7.02e-07!23;UBERON:0006562!7.34e-07!24;UBERON:0001557!7.34e-07!24;UBERON:0001042!7.34e-07!24;UBERON:0008814!7.34e-07!24;UBERON:0009145!7.34e-07!24
|ontology_enrichment_uberon=UBERON:0004119!2.95e-22!118;UBERON:0000925!2.95e-22!118;UBERON:0006595!2.95e-22!118;UBERON:0001007!9.65e-22!116;UBERON:0001555!9.65e-22!116;UBERON:0007026!9.65e-22!116;UBERON:0004921!1.76e-20!114;UBERON:0002193!1.19e-13!48;UBERON:0002405!1.19e-13!48;UBERON:0005409!2.16e-13!47;UBERON:0003929!5.03e-13!55;UBERON:0002390!5.67e-12!45;UBERON:0003061!5.67e-12!45;UBERON:0000160!1.06e-11!31;UBERON:0004923!7.81e-11!24;UBERON:0005911!2.90e-10!69;UBERON:0000344!4.39e-10!15;UBERON:0000490!1.31e-09!66;UBERON:0001041!5.38e-09!80;UBERON:0001242!7.22e-09!13;UBERON:0000060!7.22e-09!13;UBERON:0001262!7.22e-09!13;UBERON:0004786!7.22e-09!13;UBERON:0002384!2.23e-08!46;UBERON:0000077!6.81e-08!35;UBERON:0004177!1.18e-07!29;UBERON:0005057!1.18e-07!29;UBERON:0003408!4.93e-07!24;UBERON:0000072!5.06e-07!27;UBERON:0007023!5.60e-07!51;UBERON:0002370!7.02e-07!23;UBERON:0000974!7.02e-07!23;UBERON:0004807!7.02e-07!23;UBERON:0005058!7.02e-07!23;UBERON:0003351!7.02e-07!23;UBERON:0009113!7.02e-07!23;UBERON:0003295!7.02e-07!23;UBERON:0009722!7.02e-07!23;UBERON:0005562!7.02e-07!23;UBERON:0007690!7.02e-07!23;UBERON:0006562!7.34e-07!24;UBERON:0001557!7.34e-07!24;UBERON:0001042!7.34e-07!24;UBERON:0008814!7.34e-07!24;UBERON:0009145!7.34e-07!24
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.473747,0.464605,2.27918,0.346849,0.550971,1.55624,0.247459,1.31693,0.594834,0.599767,0.632897,0.247704,0.6581,0.364314,0,0.856992,0.338549,0.656199,0.143775,0.426133,0.108444,0.657163,0.345236,1.19059,0.686615,0.223823,0.572827,1.02135,0.534301,0.558142,0.960397,0.336199,0.589948,0.364821,0.144368,2.38064,0.629145,0.303703,1.37841,0.342638,0.56353,0.0995018,0.366415,1.02402,0.524258,0.77511,0.589246,0.0835644,0.397446,0.839084,0.714419,0.174327,1.10437,1.12205,0.66551,0.406788,0.619643,0.21472,0.663395,0.939962,0.724164,0.742129,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,2.94103,0.70565,1.77235,1.156,2.50016,0.57254,0.204132,0.763395,0.922432,0.430551,0.254777,0.874787,0.722675,0.240896,1.03903,1.6478,0.220054,1.02367,1.83587,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.281222,1.27104,0.976308,0.775372,0.160254,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,1.11115,0.428007,1.21641,1.0885,0.431734,0.605144,1.33732,0.90315,0.528609,0.53982,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,0.679647,1.35909,0.347287,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.348692,3.08554,0.325363,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,1.56426,0.63125,3.3831
}}
}}

Revision as of 19:34, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:126602348..126602359,+p11@B4galnt1
Mm9::chr10:126602369..126602383,+p5@B4galnt1
Mm9::chr10:126602843..126602860,+p7@B4galnt1
Mm9::chr10:126602861..126602878,+p6@B4galnt1
Mm9::chr10:126602881..126602956,+p2@B4galnt1
Mm9::chr17:46300102..46300132,+p6@Gtpbp2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0003947(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity0.00777954308880732
GO:0001574ganglioside biosynthetic process0.00972203131937673
GO:0030259lipid glycosylation0.00972203131937673
GO:0006688glycosphingolipid biosynthetic process0.00972203131937673
GO:0001573ganglioside metabolic process0.00972203131937673
GO:0009247glycolipid biosynthetic process0.00972203131937673
GO:0019915sequestering of lipid0.00972203131937673
GO:0006687glycosphingolipid metabolic process0.00972203131937673
GO:0030148sphingolipid biosynthetic process0.0121475442708201
GO:0006664glycolipid metabolic process0.0121475442708201
GO:0008376acetylgalactosaminyltransferase activity0.0121475442708201
GO:0006672ceramide metabolic process0.0121475442708201
GO:0030258lipid modification0.0121475442708201
GO:0030173integral to Golgi membrane0.0121475442708201
GO:0046519sphingoid metabolic process0.0121475442708201
GO:0031228intrinsic to Golgi membrane0.0121475442708201
GO:0006665sphingolipid metabolic process0.0191984603543554
GO:0031301integral to organelle membrane0.0215808346195295
GO:0031300intrinsic to organelle membrane0.0224864167838657
GO:0000139Golgi membrane0.0266208409274459
GO:0046467membrane lipid biosynthetic process0.0266208409274459
GO:0043413biopolymer glycosylation0.0278759404793481
GO:0008194UDP-glycosyltransferase activity0.0290209928853652
GO:0044431Golgi apparatus part0.0402455026940035
GO:0003924GTPase activity0.0402455026940035
GO:0016758transferase activity, transferring hexosyl groups0.0402455026940035
GO:0006643membrane lipid metabolic process0.0433290354045682



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
endoderm-derived structure2.95e-22118
endoderm2.95e-22118
presumptive endoderm2.95e-22118
digestive system9.65e-22116
digestive tract9.65e-22116
primitive gut9.65e-22116
subdivision of digestive tract1.76e-20114
hemolymphoid system1.19e-1348
immune system1.19e-1348
gastrointestinal system2.16e-1347
gut epithelium5.03e-1355
hematopoietic system5.67e-1245
blood island5.67e-1245
intestine1.06e-1131
organ component layer7.81e-1124
endo-epithelium2.90e-1069
mucosa4.39e-1015
unilaminar epithelium1.31e-0966
foregut5.38e-0980
intestinal mucosa7.22e-0913
anatomical wall7.22e-0913
wall of intestine7.22e-0913
gastrointestinal system mucosa7.22e-0913
connective tissue2.23e-0846
mixed endoderm/mesoderm-derived structure6.81e-0835
hemopoietic organ1.18e-0729
immune organ1.18e-0729
gland of gut4.93e-0724
segment of respiratory tract5.06e-0727
adult organism5.60e-0751
thymus7.02e-0723
neck7.02e-0723
respiratory system epithelium7.02e-0723
hemolymphoid system gland7.02e-0723
pharyngeal epithelium7.02e-0723
thymic region7.02e-0723
pharyngeal gland7.02e-0723
entire pharyngeal arch endoderm7.02e-0723
thymus primordium7.02e-0723
early pharyngeal endoderm7.02e-0723
pharynx7.34e-0724
upper respiratory tract7.34e-0724
chordate pharynx7.34e-0724
pharyngeal arch system7.34e-0724
pharyngeal region of foregut7.34e-0724


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}